Dr. J AI Wins Bid for Breast Cancer Early Screening Project in Yongchun, Quanzhou
(August 1, 2025, Quanzhou, Fujian) — Guangzhou Shangyi Internet Information Technology Co., Ltd. announced that its flagship product, the “Dr. J AI Breast Cancer Screening Robot”, has officially won the bid for the “AI Breast Cancer Screening Service Procurement Project” initiated by the Yongchun County Maternal and Child Health Hospital in Quanzhou City, Fujian Province.
This successful bid marks a major breakthrough for Dr. J AI in the Fujian market and represents the first tangible outcome of the strategic collaboration between Dr. J and the Quanzhou Municipal Government. It also signifies the launch of a new model of public-private partnership to advance AI-powered breast cancer screening.
Government-Enterprise Synergy Accelerates Strategic Deployment
This project follows the July 22 signing of a strategic cooperation memorandum between the Dr. J team, its key strategic investor — Japan’s Sojitz Corporation (a Fortune Global 500 enterprise) — and the Quanzhou Municipal Government.
The project showcases Quanzhou’s open, innovative, and execution-driven business environment, where top-level strategy is rapidly translated into public benefit. Backed by strong support from the Quanzhou government and high-level commitment from Yongchun County leaders, the Dr. J AI Screening Robot was designated as a priority initiative to improve women’s health and was described as something that “must be done — and done well.”
As a pilot demonstration project for Quanzhou, the Yongchun initiative will offer efficient, accurate, and accessible early breast cancer screening services — powered by advanced AI technology — to over 10,000 local women.
AI-Powered Screening Model Upgrades Primary Healthcare
Recognizing the challenges faced by grassroots hospitals — including limited medical personnel, lack of experience, and technological barriers — Dr. J introduced a turnkey “One-Stop AI Screening Service” solution to help hospitals deploy the system quickly and efficiently.
With no need for significant equipment investment, hospitals can instantly access advanced AI-powered screening capabilities. The Dr. J AI Breast Cancer Screening Robot can:
- Automatically analyze real-time ultrasound video
- Intelligently detect and locate lesions
- Classify findings based on BI-RADS and other clinical criteria
Operators can be trained in a short time to deliver screening services, dramatically increasing efficiency and accuracy. Its low cost, high scalability, and ease of use make it a revolutionary technology for large-scale population screening.
More importantly, this model extends beyond disease detection — enabling a shift toward preventive health management, unlocking new service scenarios and creating sustainable revenue growth opportunities for local healthcare institutions.
A Vision for the Future
According to project plans, Yongchun County will provide high-quality breast cancer screenings to 10,000 women in 2025 — just the beginning. The goal is to scale up to 50,000 screenings annually, expanding access to a wider population of eligible women and building a comprehensive, efficient women’s health safety net.
As Dr. J’s first project in Fujian Province, Yongchun serves as a regional model for AI breast screening deployment, showcasing how artificial intelligence can empower public health at the county level. It reflects the government’s strong commitment to improving public health and demonstrates the real-world impact of AI technology in medical services.
Looking ahead, Dr. J will continue to drive innovation and collaborate with more local governments, ensuring high-quality, sustainable early screening services take root and benefit people at scale. The mission: to empower women’s health with the power of technology.
Empowering Women’s Health with AI Innovation
Dr. J — Safeguarding Her Health, Powered by AI.